1132841-45-2

Basic information

• Product Name: (2R,3S)-1-(3-dimethylamino)benzylamino-2-hydroxy-3-amino-4-phenyl-butane
• Synonyms: (2R,3S)-1-(3-dimethylamino)benzylamino-2-hydroxy-3-amino-4-phenyl-butane
• CAS NO: 1132841-45-2
• Molecular Weight: 313.443
• Mol File: 1132841-45-2.mol

Chemical Properties

• CAS DataBase Reference: (2R,3S)-1-(3-dimethylamino)benzylamino-2-hydroxy-3-amino-4-phenyl-butane(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,3S)-1-(3-dimethylamino)benzylamino-2-hydroxy-3-amino-4-phenyl-butane(1132841-45-2)
• EPA Substance Registry System: (2R,3S)-1-(3-dimethylamino)benzylamino-2-hydroxy-3-amino-4-phenyl-butane(1132841-45-2)

Safety Data

• Hazardous Substances Data: 1132841-45-2(Hazardous Substances Data)

Upstream product

• 1132841-13-4 [(1S,2R)-1-benzyl-3-(3-dimethylamino-benzylamino)-2-hydroxy-propyl]-carbamic acid t-butyl ester 

Downstream Products

• 1037222-47-1 C₃₁H₃₆F₃N₅O₃ 
• 1037222-48-2 (4S)-N-[(2S,3R)-4-(3-dimethylaminophenyl)methylamino-3-hydroxy-1-phenylbutan-2-yl]-2-oxo-1-[(4-trifluoromethylphenyl)methyl]imidazolidine-4-carboxamide 
• 1037222-38-0 (4S)-1-(3,5-dibromo)phenyl-N-[(2S,3R)-4-(3-dimethylaminophenyl)methylamino-3-hydroxy-1-phenylbutan-2-yl]-2-oxoimidazolidine-4-carboxamide 
• 1037222-39-1 (4S)-N-[(2S,3R)-4-(3-dimethylaminophenyl)methylamino-3-hydroxy-1-phenylbutan-2-yl]-2-oxo-1-phenylimidazolidine-4-carboxamide 
• 1037222-31-3 (4S)-1-benzyl-[(2S,3R)4-(3-dimethylaminophenyl)methylamino-3-hydroxy-1-phenylbutan-2-yl]-2-oxoimidazolidine-4-carboxamide 
• 1037222-32-4 (4S)-N-[(2S,3R)-4-(3-dimethylaminophenyl)methylamino-3-hydroxy-1-phenylbutan-2-yl]-2-oxoimidazolidine-4-carboxamide 
• 1132841-44-1 N-[(2S,3R)-4-[(3-dimethylaminophenyl)methylamino]-3-hydroxy-1-phenylbutan-2-yl]-5-oxo-1-phenyl-4H-pyrazole-3-carboxamide 
• 1134289-80-7 (2S)-N-[(2S,3R)-4-[(3-dimethylaminophenyl)methylamino]-3-hydroxy-1-phenylbutan-2-yl]-5-oxopyrrolidine-2-carboxamide 
• 1037222-46-0 (4S)-N-[(2S,3R)-4-(3-dimethylaminophenyl)methylamino-3-hydroxy-1-phenylbutan-2-yl]-2-oxo-1-[(2,4,5-trifluorophenyl)methyl]imidazolidine-4-carboxamide 
• 1037222-45-9 (4S)-1-(3,5-difluorophenyl)methyl-N-[(2S,3R)-4-(3-dimethylaminophenyl)methylamino-3-hydroxy-1-phenylbutan-2-yl]-2-oxoimidazolidine-4-carboxamide 
• 1037222-44-8 (4S)-1-(2,4-difluorophenyl)methyl-N-[(2S,3R)-4-(3-dimethylaminophenyl)methylamino-3-hydroxy-1-phenylbutan-2-yl]-2-oxoimidazolidine-4-carboxamide 
• 1037222-43-7 (4S)-1-(3,4-difluorophenyl)methyl-N-[(2S,3R)-4-(3-dimethylaminophenyl)methylamino-3-hydroxy-1-phenylbutan-2-yl]-2-oxoimidazolidine-4-carboxamide 
• 1037222-42-6 (4S)-N-[(2S,3R)-4-(3-dimethylaminophenyl)methylamino-3-hydroxy-1-phenylbutan-2-yl]-1-[(4-fluorophenyl)methyl]-2-oxoimidazolidine-4-carboxamide 
• 1037222-41-5 (4S)-1-(3,5-dimethoxyphenyl)methyl-N-[(2S,3R)-4-(3-dimethylaminophenyl)methylamino-3-hydroxy-1-phenylbutan-2-yl]-2-oxoimidazolidine-4-carboxamide 

Relevant articles and documents

BETA-SECRETASE INHIBITING COMPOUNDS HAVING OXO-DIHYDRO-PYRAZOLE MOIETY

Disclosed are compounds represented by Formula (I) as defined in the specification, or pharmaceutically acceptable salts or isomers thereof, and a pharmaceutical composition for inhibiting beta-secretase activity comprising a therapeutically effective amo

BETA-SECRETASE INHIBITING COMPOUNDS

Disclosed are compounds represented by Formula (I) as defined in the specification, or pharmaceutically acceptable salts or isomers thereof, and a pharmaceutical composition for inhibiting beta-secretase activity comprising a therapeutically effective amount of the same.